Abstract-Vitamin D is a neuroactive steroid. Its genomic actions are mediated via the active form of vitamin D, 1,25(OH) 2 D 3 , binding to the vitamin D receptor (VDR). The VDR emerges in the rat mesencephalon at embryonic day 12, representing the peak period of dopaminergic cell birth. Our prior studies reveal that developmental vitamin D (DVD)-deficiency alters the ontogeny of dopaminergic neurons in the developing mesencephalon. There is also consistent evidence from others that 1,25(OH) 2 D 3 promotes the survival of dopaminergic neurons in models of dopaminergic toxicity. In both developmental and toxicological studies it has been proposed that 1,25(OH) 2 D 3 may modulate the differentiation and maturation of dopaminergic neurons; however, to date there is lack of direct evidence. The aim of the current study is to investigate this both in vitro using a human SH-SY5Y cell line transfected with rodent VDR and in vivo using a DVD-deficient model. Here we show that in VDR-expressing SH-SY5Y cells, 1,25(OH) 2 D 3 significantly increased production of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis. This effect was dose-and time-dependent, but was not due to an increase in TH-positive cell number, nor was it due to the production of trophic survival factors for dopamine neurons such as glial-derived neurotrophic factor (GDNF). In accordance with 1,25(OH) 2 D 3 's anti-proliferative actions in the brain, 1,25(OH) 2 D 3 reduced the percentage of dividing cells from approximately 15-10%. Given the recently reported role of N-cadherin in the direct differentiation of dopaminergic neurons, we examined here whether it may be elevated by 1,25(OH) 2 D 3 . We confirmed this in vitro and more importantly, we showed DVD-deficiency decreases N-cadherin expression in the embryonic mesencephalon. In summary, in our in vitro model we have shown 1,25(OH) 2 D 3 increases TH expression, decreases proliferation and elevates N-cadherin, a potential factor that mediates these processes. Accordingly all of these findings are reversed in the developing brain in our DVD-deficiency model. Remarkably our findings in the DVD-deficiency model phenocopy those found in a recent model where N-cadherin was regionally ablated from the mesencephalon. This study has, for the first time, shown that vitamin D directly modulates TH expression and strongly suggests N-cadherin may be a plausible mediator of this process both in vitro and in vivo. Our findings may help to explain epidemiological data linking DVD deficiency with schizophrenia. Ó 2015 Published by Elsevier Ltd. on behalf of IBRO.
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INTRODUCTION

12
Vitamin D is a steroid hormone and exerts diverse 13 physiological functions that extend beyond its classical 14 role in calcium and bone homeostasis (Jones et al., 15 1998). Several lines of evidence indicate vitamin D is 16 important for both developing and adult brains (Eyles 17 et al., 2009 (Eyles 17 et al., , 2010 (Eyles 17 et al., , 2013 . In particular, our recent findings 18 reveal the role that vitamin D may play in developing 19 dopaminergic neurons (Cui et al., , 2013 Eyles 20 et al., 2014) . Based on epidemiological findings, prenatal (Valipour et al., 2014) . Low levels of vitamin D have also 31 been detected in patients with Parkinson's disease 32 (Newmark and Newmark, 2007; Evatt et al., 2008 Evatt et al., , 2011  dopamine receptor antagonist, haloperidol (Kesby et al., 48 2006 Nurr1 and p57kip2, in mesencephalon .
59
Finally DVD-deficiency has also very recently been shown 60 to down-regulate TH gene and protein expression in the 61 embryonic brains of female mice (Hawes et al., 2015 hydroxydopamine (6-OHDA) (Wang et al., 2001; Smith 71 et al., 2006; Cass et al., 2012 Cass et al., , 2014 on dopaminergic neurons, GDNF has also been found to 76 be able to restore evoked dopamine levels after 6-OHDA-77 induced striatal damage (Cass and Manning, 1999 Cass et al., 2014 (Sanchez et al., 2009) . 1,25(OH) 2 D 3 has 89 also been shown to increase TH-positive cell number in 90 the SN of 6-OHDA-lesioned mice (Puchacz et al., 1996) . developing rat mesencephalon (Veenstra et al., 1998 (Cui et al., 2013 The pTarget-VDR construct was transfected into human elsewhere (Eyles et al., 2009 10-fold in cell lysates (Fig. 1B, t = 6 .448, p < 0.01, (Puchacz et al., 1996) . Unfortunately only TH mRNA 461 levels were examined in that study, with neither TH pro- (Wang et al., 2001; Cass et al., 2006; Smith et al., 2006;  466 Sanchez et al., 2009; Cass et al., 2012 Cass et al., , 2014 . These data In vivo (DVD-deficiency) Regional N-cadherin knock-out (Sakane and Miyamoto, 2013) N-cadherin " ; ; Cell proliferation ; " Ko et al., 2004; Cui et al., 2007) Ko et al., 2004) 545 and increased neurosphere number (Cui et al., 2007) . oping rat (Ko et al., 2004 25-50% in SH-SY5Y cells (Gumireddy et al., 2003a,b 
